Results 21 to 30 of about 29,446 (242)
Asian Journal of Medical Sciences, 2022 Background: Vitiligo is a common acquired skin disease characterized by depigmented macules and patches due to loss of functional melanocytes. Childhood-onset vitiligo has distinct epidemiological and clinical characteristics as compared to that of late ...
Swapan Majumder +3 more
doaj +1 more source
Vitiligo and autoimmune diseases [PDF]
, 2016 Vitiligo is a quite frequently occurring skin disease. Although it does not cause any pain or internal organ damage, it constitutes a significant cosmetic problem having a significant impact on quality of life.
Magdalena Kutwin +2 more
core +1 more source
Increased Risk of Metabolic Syndrome in Patients with Vitiligo
Balkan Medical Journal, 2017 The risk of developing metabolic syndrome is increased in patients with vitiligo. The poor clinical features of vitiligo, such as active, extended and segmental vitiligo with an increased duration of time, are independent predictors for developing ...
Hatice Ataş, Müzeyyen Gönül
doaj +1 more source
A clinico-epidemiological study on childhood vitiligo
Indian Journal of Paediatric Dermatology, 2016 Introduction: Vitiligo is a disorder of melanocytes which may have a significant effect on the psyche of a patient. Aims: To study the clinical profile of the patients with childhood vitiligo and see the association of vitiligo with other autoimmune ...
Neerja Puri
doaj +1 more source
Clinical Features of Vitiligo and Social Impact on Quality of Life
Dermatology Practical & Conceptual, 2023 Vitiligo is the most common cause of depigmentation and its estimated worldwide prevalence ranges from 0.5% to 2%. The disease is characterized by the development of white macules resulting from a loss of epidermal melanocytes.
Seneschal Julien
doaj +1 more source
Low frequency of skin cancers in vitiligo patients [PDF]
, 2016 Vitiligo is a disease characterized by discoloration of the skin and hair as a result of damage of melanocytes. The exact mechanism of the disease is still unknown.
Anna Erkiert-Polguj +4 more
core +1 more source
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: Results of the HI-Light Vitiligo Trial [PDF]
, 2022 BACKGROUND: Evidence for the effectiveness of vitiligo treatments is limited., OBJECTIVES: To determine the effectiveness of (i) handheld narrowband UVB (NB-UVB) and (ii) a combination of potent topical corticosteroid (TCS) and NB-UVB, compared with TCS ...
Rogers, Andy +3 more
core +1 more source
Prepubertal and postpubertal vitiligo: a multivariate comparative study in 375 patients [PDF]
Anais Brasileiros de Dermatologia, 2017 : Background: The onset of vitiligo during childhood is common. Limited data exist that compare the clinical associations of prepubertal and postpubertal vitiligo in Arabs.
Huma Khurrum, Khalid M AlGhamdi
doaj +1 more source
Psoriasis on Lesions of Vitiligo: A Case Report [PDF]
, 2023 Lijuan Wang,1 Bin Zhang1,2 1Department of Dermatology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China; 2Department of Dermatology, Children’s Hospital Affiliated
Zhang B, Wang L
core
Serum interleukin 15 as a marker of activity in patients with vitiligo
Journal of the Egyptian Women’s Dermatologic Society, 2021 Background Interleukin 15 (IL15) is a proinflammatory cytokine that is involved in the pathogenesis of several autoimmune and inflammatory diseases. The stability of vitiligo represents the periods of no activity of the disease, and it is crucial in ...
Ashraf Hamza +3 more
doaj +1 more source